TP53 and cancer: This oncogene-induced RS, on the one hand, promotes cancer development by increasing genomic instability and promoting the loss of p53 Halazonetis et al., 2008; on the other hand, it is a burden for cancer cells, which must deal with chronic replication defects and may become dependent on checkpoint function for their survival.